Bulletin
Investor Alert

Gilead Sciences Inc.

NAS: GILD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210293917/composite

$

63.18

Change

0.00 0.00%

Volume

Volume 324,533

May 17, 2022, 7:56 p.m.

Real time quotes

/zigman2/quotes/210293917/composite

Today's close

$ 62.24

$ 63.18

Change

+0.94 +1.51%

Day low

Day high

$61.80

$63.22

Open
Open: 62.42

52 week low

52 week high

$57.19

$74.12

Open

Market cap

$78.07B

Average volume

9.34M

P/E ratio

17.65

Rev. per Employee

$1.91M

EPS

3.58

Dividend

0.73

Div yield

4.62%

Ex dividend date

6/14/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gild

MarketWatch News on GILD

  1. New Roche Cancer Data Slams Biopharma Stocks

    10:38 a.m. May 11, 2022

    - Josh Nathan-Kazis

  2. FDA formally approves Gilead's Veklury for young children

    2:20 p.m. April 25, 2022

    - Jaimy Lee

  3. U.S. Stocks Poised to Open Lower on Monday

    6:39 p.m. April 24, 2022

    - Janet H. Cho

  4. Yes, You Can Get Dividend Yields Around 5%. Just Be Careful.

    5:25 p.m. April 24, 2022

    - Lawrence C. Strauss

  5. 6 Defensive Healthcare Stocks With High Dividend Yields

    7:31 p.m. April 20, 2022

    - Josh Nathan-Kazis

  6. Sierra Oncology Soars After Takeover by Glaxo

    9:40 a.m. April 13, 2022

    - Lina Saigol

  7. 8 S&P 500 Stocks That Are Still Negative Since the Pandemic Lows

    10:41 a.m. March 27, 2022

    - Connor Smith

  8. Covid-19 Cases Climb in U.K. as BA.2 Spreads

    1:39 p.m. March 12, 2022

    - Josh Nathan-Kazis

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/gild

Other News on GILD

  1. Gilead (GILD) HIV Studies Removed From FDA's Clinical Hold

    11:30 a.m. Today

    - Zacks.com

  2. Gilead granted FDA nod to resume HIV studies for injectable lenacapavir

    7:27 a.m. Today

    - Seeking Alpha

  3. Should You Invest in the VanEck Biotech ETF (BBH)?

    6:20 a.m. May 16, 2022

    - Zacks.com

  4. Top 5 1st Quarter Trades of Cadence Bank

    5:00 a.m. May 16, 2022

    - GuruFocus.com

  5. Former Immunomedics CFO indicted on insider trading allegations

    12:21 p.m. May 11, 2022

    - Seeking Alpha

  6. 2 Red Flags for Gilead Sciences' Future

    11:45 a.m. May 11, 2022

    - Motley Fool

  7. Silver Ring Value Partners Q1 2022 Partner Letter

    11:49 p.m. May 10, 2022

    - Seeking Alpha

  8. VFVA: Riskier Than Other Value ETFs

    7:30 p.m. May 9, 2022

    - Seeking Alpha

  9. Bristol-Myers Has the Stalest Product Line, Says Evaluate

    2:07 p.m. May 9, 2022

    - GuruFocus.com

  10. Loading more headlines...
/news/pressrelease/company/us/gild

Press Releases on GILD

  1. Nasdaq 100 Movers: GILD, LCID

    10:45 a.m. May 13, 2022

    - MarketNewsVideo.com

  2. Gilead Sciences GILD Trading Report

    11:36 p.m. May 12, 2022

    - Stock Traders Daily

  3. Gilead Sciences GILD Trading Signals

    7:21 a.m. May 3, 2022

    - Stock Traders Daily

  4. Top Pharmaceutical Stocks To Watch In May 2022

    9:45 a.m. April 30, 2022

    - StockMarket.com

  5. Gilead Sciences Announces First Quarter 2022 Financial Results

    4:02 p.m. April 28, 2022

    - BusinessWire - BZX

  6. Thursday's ETF with Unusual Volume: IDNA

    12:31 p.m. April 28, 2022

    - MarketNewsVideo.com

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.